Literature DB >> 1346175

Control of scarring in adult wounds by neutralising antibody to transforming growth factor beta.

M Shah1, D M Foreman, M W Ferguson.   

Abstract

Adult wounds heal with scar-tissue formation, whereas fetal wounds heal without scarring and with a lesser inflammatory and cytokine response. We injected the margins of healing dermal wounds in adult rats with neutralising antibody (NA) to transforming growth factor-beta (TGF-beta). All control wounds (irrelevant antibody, or TGF-beta, or no injection) healed with scarring, whereas the NA-treated wounds healed without scar-tissue formation; NA-treated wounds had fewer macrophages and blood vessels, lower collagen and fibronectin contents, but identical tensile strength and more normal dermal architecture than the other wounds. Early manipulation of the concentrations of selected cytokines may be a new approach to the control of scarring.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1346175     DOI: 10.1016/0140-6736(92)90009-r

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  96 in total

1.  Fibrodynamics-elucidation of the mechanisms and sites of liver fibrogenesis.

Authors:  Catherine H Wu
Journal:  World J Gastroenterol       Date:  1999-10       Impact factor: 5.742

Review 2.  Strategies to influence PVR development.

Authors:  Bernd Kirchhof
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-08-10       Impact factor: 3.117

Review 3.  [Fetal wound healing: current status and new perspectives].

Authors:  E A Huhn; C Jannowitz; H Boos; M A Papadopulos; H F Zeilhofer; J Henke; D Müller; L Kovacs; E Biemer; N A Papadopulos
Journal:  Chirurg       Date:  2004-05       Impact factor: 0.955

Review 4.  Aging and wound healing.

Authors:  Ankush Gosain; Luisa A DiPietro
Journal:  World J Surg       Date:  2004-02-17       Impact factor: 3.352

Review 5.  Current strategies and future perspectives for intraperitoneal adhesion prevention.

Authors:  Christoph Brochhausen; Volker H Schmitt; Constanze N E Planck; Taufiek K Rajab; David Hollemann; Christine Tapprich; Bernhard Krämer; Christian Wallwiener; Helmut Hierlemann; Rolf Zehbe; Heinrich Planck; C James Kirkpatrick
Journal:  J Gastrointest Surg       Date:  2012-06       Impact factor: 3.452

6.  Innovative therapies in the treatment of keloids and hypertrophic scars.

Authors:  Martha H Viera; Sadegh Amini; Whitney Valins; Brian Berman
Journal:  J Clin Aesthet Dermatol       Date:  2010-05

Review 7.  Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies.

Authors:  Gerd G Gauglitz; Hans C Korting; Tatiana Pavicic; Thomas Ruzicka; Marc G Jeschke
Journal:  Mol Med       Date:  2010-10-05       Impact factor: 6.354

Review 8.  Role of transforming growth factor Beta in corneal function, biology and pathology.

Authors:  A Tandon; J C K Tovey; A Sharma; R Gupta; R R Mohan
Journal:  Curr Mol Med       Date:  2010-08       Impact factor: 2.222

9.  Fibromodulin Is Essential for Fetal-Type Scarless Cutaneous Wound Healing.

Authors:  Zhong Zheng; Xinli Zhang; Catherine Dang; Steven Beanes; Grace X Chang; Yao Chen; Chen-Shuang Li; Kevin S Lee; Kang Ting; Chia Soo
Journal:  Am J Pathol       Date:  2016-09-22       Impact factor: 4.307

10.  Cellular localization of transforming growth factor-beta expression in bleomycin-induced pulmonary fibrosis.

Authors:  K Zhang; K C Flanders; S H Phan
Journal:  Am J Pathol       Date:  1995-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.